世界の子宮内膜がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endometrial Cancer Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2156 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、子宮内膜がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、放射線療法、手術）、用途別市場規模（研究所、病院・クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮内膜がん治療の市場動向 ・企業の競争状況、市場シェア ・子宮内膜がん治療の種類別市場規模（化学療法、ホルモン療法、放射線療法、手術） ・子宮内膜がん治療の用途別市場規模（研究所、病院・クリニック） ・子宮内膜がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・子宮内膜がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮内膜がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮内膜がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮内膜がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、F. Hoffman La Roche Ltd.、Bristol-Myers Squibb Company、Merck KGaA、Novartis AG、Takeda Pharmaceutical Company Limited、Eli Lilly and Company、Sanofi、GlaxoSmithKline plc、ArQule, Inc.） ・結論

Market Analysis and Insights: Global Endometrial Cancer Therapeutics Market
The global Endometrial Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometrial Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometrial Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometrial Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometrial Cancer Therapeutics market.

Global Endometrial Cancer Therapeutics Scope and Market Size
Endometrial Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometrial Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Hormone Therapy
Radiation Therapy
Surgery

Segment by Application
Research Institutes
Hospitals & Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
F. Hoffman La Roche Ltd.
Bristol-Myers Squibb Company
Merck KGaA
Novartis AG
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Sanofi
GlaxoSmithKline plc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometrial Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Hormone Therapy
1.2.4 Radiation Therapy
1.2.5 Surgery
1.3 Market by Application
1.3.1 Global Endometrial Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endometrial Cancer Therapeutics Market Perspective (2016-2027)
2.2 Endometrial Cancer Therapeutics Growth Trends by Regions
2.2.1 Endometrial Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometrial Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Endometrial Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Endometrial Cancer Therapeutics Industry Dynamic
2.3.1 Endometrial Cancer Therapeutics Market Trends
2.3.2 Endometrial Cancer Therapeutics Market Drivers
2.3.3 Endometrial Cancer Therapeutics Market Challenges
2.3.4 Endometrial Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endometrial Cancer Therapeutics Players by Revenue
3.1.1 Global Top Endometrial Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Endometrial Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Endometrial Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometrial Cancer Therapeutics Revenue
3.4 Global Endometrial Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Endometrial Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometrial Cancer Therapeutics Revenue in 2020
3.5 Endometrial Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Endometrial Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Endometrial Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endometrial Cancer Therapeutics Breakdown Data by Type
4.1 Global Endometrial Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Endometrial Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Endometrial Cancer Therapeutics Breakdown Data by Application
5.1 Global Endometrial Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Endometrial Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endometrial Cancer Therapeutics Market Size (2016-2027)
6.2 North America Endometrial Cancer Therapeutics Market Size by Type
6.2.1 North America Endometrial Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Endometrial Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Endometrial Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Endometrial Cancer Therapeutics Market Size by Application
6.3.1 North America Endometrial Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Endometrial Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Endometrial Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Endometrial Cancer Therapeutics Market Size by Country
6.4.1 North America Endometrial Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Endometrial Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endometrial Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Endometrial Cancer Therapeutics Market Size by Type
7.2.1 Europe Endometrial Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Endometrial Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Endometrial Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Endometrial Cancer Therapeutics Market Size by Application
7.3.1 Europe Endometrial Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Endometrial Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Endometrial Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Endometrial Cancer Therapeutics Market Size by Country
7.4.1 Europe Endometrial Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Endometrial Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endometrial Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometrial Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endometrial Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Endometrial Cancer Therapeutics Market Size by Type
9.2.1 Latin America Endometrial Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Endometrial Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Endometrial Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Endometrial Cancer Therapeutics Market Size by Application
9.3.1 Latin America Endometrial Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Endometrial Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Endometrial Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Endometrial Cancer Therapeutics Market Size by Country
9.4.1 Latin America Endometrial Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Endometrial Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endometrial Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometrial Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Endometrial Cancer Therapeutics Introduction
11.1.4 Bayer AG Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 F. Hoffman La Roche Ltd.
11.2.1 F. Hoffman La Roche Ltd. Company Details
11.2.2 F. Hoffman La Roche Ltd. Business Overview
11.2.3 F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Introduction
11.2.4 F. Hoffman La Roche Ltd. Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.2.5 F. Hoffman La Roche Ltd. Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Endometrial Cancer Therapeutics Introduction
11.4.4 Merck KGaA Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.4.5 Merck KGaA Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Endometrial Cancer Therapeutics Introduction
11.5.4 Novartis AG Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Takeda Pharmaceutical Company Limited
11.6.1 Takeda Pharmaceutical Company Limited Company Details
11.6.2 Takeda Pharmaceutical Company Limited Business Overview
11.6.3 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Introduction
11.6.4 Takeda Pharmaceutical Company Limited Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.6.5 Takeda Pharmaceutical Company Limited Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Endometrial Cancer Therapeutics Introduction
11.7.4 Eli Lilly and Company Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Endometrial Cancer Therapeutics Introduction
11.8.4 Sanofi Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Details
11.9.2 GlaxoSmithKline plc Business Overview
11.9.3 GlaxoSmithKline plc Endometrial Cancer Therapeutics Introduction
11.9.4 GlaxoSmithKline plc Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.9.5 GlaxoSmithKline plc Recent Development
11.10 ArQule, Inc.
11.10.1 ArQule, Inc. Company Details
11.10.2 ArQule, Inc. Business Overview
11.10.3 ArQule, Inc. Endometrial Cancer Therapeutics Introduction
11.10.4 ArQule, Inc. Revenue in Endometrial Cancer Therapeutics Business (2016-2021)
11.10.5 ArQule, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endometrial Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormone Therapy
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Surgery
Table 6. Global Endometrial Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometrial Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometrial Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometrial Cancer Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Endometrial Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometrial Cancer Therapeutics Market Share by Regions (2022-2027)
Table 12. Endometrial Cancer Therapeutics Market Trends
Table 13. Endometrial Cancer Therapeutics Market Drivers
Table 14. Endometrial Cancer Therapeutics Market Challenges
Table 15. Endometrial Cancer Therapeutics Market Restraints
Table 16. Global Endometrial Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometrial Cancer Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Endometrial Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer Therapeutics as of 2020)
Table 19. Ranking of Global Top Endometrial Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometrial Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometrial Cancer Therapeutics Product Solution and Service
Table 23. Date of Enter into Endometrial Cancer Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometrial Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Endometrial Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometrial Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometrial Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometrial Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Endometrial Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometrial Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometrial Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometrial Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometrial Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometrial Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometrial Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometrial Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometrial Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometrial Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometrial Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometrial Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometrial Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometrial Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometrial Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometrial Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometrial Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometrial Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometrial Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer AG Company Details
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Endometrial Cancer Therapeutics Product
Table 66. Bayer AG Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Bayer AG Recent Development
Table 68. F. Hoffman La Roche Ltd. Company Details
Table 69. F. Hoffman La Roche Ltd. Business Overview
Table 70. F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Product
Table 71. F. Hoffman La Roche Ltd. Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 72. F. Hoffman La Roche Ltd. Recent Development
Table 73. Bristol-Myers Squibb Company Company Details
Table 74. Bristol-Myers Squibb Company Business Overview
Table 75. Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Product
Table 76. Bristol-Myers Squibb Company Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Company Recent Development
Table 78. Merck KGaA Company Details
Table 79. Merck KGaA Business Overview
Table 80. Merck KGaA Endometrial Cancer Therapeutics Product
Table 81. Merck KGaA Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Merck KGaA Recent Development
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Endometrial Cancer Therapeutics Product
Table 86. Novartis AG Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. Takeda Pharmaceutical Company Limited Company Details
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Product
Table 91. Takeda Pharmaceutical Company Limited Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Limited Recent Development
Table 93. Eli Lilly and Company Company Details
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company Endometrial Cancer Therapeutics Product
Table 96. Eli Lilly and Company Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Eli Lilly and Company Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. GlaxoSmithKline plc Company Details
Table 103. GlaxoSmithKline plc Business Overview
Table 104. GlaxoSmithKline plc Endometrial Cancer Therapeutics Product
Table 105. GlaxoSmithKline plc Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 106. GlaxoSmithKline plc Recent Development
Table 107. ArQule, Inc. Company Details
Table 108. ArQule, Inc. Business Overview
Table 109. ArQule, Inc. Endometrial Cancer Therapeutics Product
Table 110. ArQule, Inc. Revenue in Endometrial Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 111. ArQule, Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometrial Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Hormone Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Surgery Features
Figure 6. Global Endometrial Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Research Institutes Case Studies
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Endometrial Cancer Therapeutics Report Years Considered
Figure 10. Global Endometrial Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Endometrial Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Endometrial Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Endometrial Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Endometrial Cancer Therapeutics Market Share by Players in 2020
Figure 15. Global Top Endometrial Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometrial Cancer Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Endometrial Cancer Therapeutics Revenue in 2020
Figure 17. Global Endometrial Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Endometrial Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Endometrial Cancer Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Endometrial Cancer Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Endometrial Cancer Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endometrial Cancer Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Endometrial Cancer Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Endometrial Cancer Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endometrial Cancer Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Endometrial Cancer Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Endometrial Cancer Therapeutics Market Share by Region (2016-2027)
Figure 39. China Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endometrial Cancer Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Endometrial Cancer Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Endometrial Cancer Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endometrial Cancer Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Endometrial Cancer Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Endometrial Cancer Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Endometrial Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer AG Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 59. F. Hoffman La Roche Ltd. Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 61. Merck KGaA Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 63. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 66. GlaxoSmithKline plc Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 67. ArQule, Inc. Revenue Growth Rate in Endometrial Cancer Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---